200 Technology SquareCambridge, MA 02139
Moderna, Inc. is incorporated under the laws of the State of Delaware.
Moderna, Inc. began trading on the Nasdaq Global Select Market on December 7, 2018. The initial price was $23.00 per share.
Moderna, Inc.’s fiscal year-end is December 31st.
Moderna, Inc.’s is traded on the Nasdaq Global Select Market under the ticker symbol MRNA and its CUSIP number is 60770K 107.
Moderna, Inc. does not pay dividends.
ComputershareP.O. Box 505000Louisville, KY 40233-5000(800) 736-3001 (US, Canada, Puerto Rico)(781) 575-3100 (non-US)web.queries@computershare.com
Please contact Computershare Customer Service. Computershare representatives can provide you with information about your account, to change your address and can also provide detailed instructions about how to transfer ownership.Telephone inquiries:(800) 736-3001 (US, Canada, Puerto Rico)(781) 575-3100 (non-US)Written requests:ComputershareP.O. Box 505000Louisville, KY 40233-5000By overnight delivery:Computershare462 South 4th Street, Suite 1600Louisville KY 40202Email:web.queries@computershare.com
Moderna, Inc. does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.
Moderna, Inc.’s auditor is Ernst & Young, LLP Boston, MA 02116.
Moderna, Inc.’s outside legal counsel is Goodwin Procter LLP in Boston, MA, (617) 570-1000.
Refer to the SEC Filings portion of the Investors website or directly from the SEC at www.sec.gov.
Inquiries can be submitted to IR@modernatx.com